We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




High Dose-Rate Brachytherapy Afterloader Supplied to Leading Cancer Hospital in China

By MedImaging International staff writers
Posted on 31 Mar 2011
Print article
Cancer patients in China will gain access to cutting edge cancer care with the announcement that a leading cancer center is acquiring a brachytherapy afterloader.

The GammaMed device is the first high dose-rate afterloader supplied to Chinese hospitals by Varian Medical Systems, Inc. (Palo Alto, CA, USA), a world leader in radiotherapy systems. Jilin University No. 1 Hospital (Jilin, China) will shortly begin offering treatments using the new equipment, which was ordered in late December 2010 and installed in mid-February 2011. The hospital is the leading oncology center in Jilin province, in the northeast of China.

Brachytherapy treats cancer by placing radioactive sources directly into or next to the area requiring treatment, enabling clinicians to deliver a high dose with minimal impact on surrounding healthy tissues. Brachytherapy has been employed in the treatment of tumors of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck, as well as soft tissue sarcomas and several other types of cancer.

Clinicians at Jilin reported that early brachytherapy treatments would focus on cervical and rectal cancers. The decision to install Varian machines was based on the company's reputation for advanced systems and excellent service, as well as a desire to integrate the hospital's brachytherapy offering with its external beam systems, which are also supplied by Varian Medical Systems. Deng Fei, Varian's sales manager in China, said, "Jilin University No. 1 Hospital is striving for an integrated clinical environment based on one of the most advanced technologies available.”

Tom Duffy, Varian's head of oncology systems business in Asia, said, "Varian brings its expertise as the world leader in external beam radiotherapy to its brachytherapy offerings, which we are now licensed to sell in China. Brachytherapy is a clinically proven way of placing high dose within the tumor, and computer-controlled afterloaders allow this process to be undertaken in a precise and efficient manner. We are pleased to be working with this leading cancer center to bring Varian's brachytherapy treatment systems to China.”

Related Links:

Varian Medical Systems



New
MRI Infusion Workstation
BeneFusion MRI Station
Computed Tomography System
Aquilion ONE / INSIGHT Edition
40/80-Slice CT System
uCT 528
Wall Fixtures
MRI SERIES

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.